Elms Steve

Elms Steve is listed in filings as Director at ADMA Biologics, Inc.. This profile follows SEC Form 4 activity through Mar 9, 2026, including purchase activity and sale activity. Recent filings connect the profile to ADMA Biologics, Inc. (ADMA), Marker Therapeutics, Inc. (MRKR), and Elevation Oncology, Inc. (ELEV). The current snapshot covers public activity from Jun 17, 2024 to Mar 9, 2026. Reported amounts are shown as $107.7K to $290.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.